Social Determinants of Health Shape Pain Outcomes in Sickle Cell Disease
HCPLive
OCTOBER 8, 2024
Education and employment, social and emotional functioning, and healthcare access are notable factors influencing pain in sickle cell disease.
HCPLive
OCTOBER 8, 2024
Education and employment, social and emotional functioning, and healthcare access are notable factors influencing pain in sickle cell disease.
HCPLive
MARCH 25, 2024
Chronic kidney disease was linked to increased mortality, higher costs, and the need for mechanical ventilation among hospitalized patients with sickle cell disease.
HCPLive
APRIL 3, 2024
Our March 2024 month-in-review in hematology features updates to the anemia pipeline, the latest research in sickle cell disease, and the role of SGLT2 inhibition on hematologic outcomes.
HCPLive
JUNE 20, 2024
Early detection from a universal newborn screening program in Canada significantly reduced disease-related burden in children with SCD.
HCPLive
APRIL 9, 2024
A systematic review and meta-analysis of HSCT in children with sickle cell disease demonstrated pooled survival rates exceeding 90%.
HCPLive
DECEMBER 4, 2024
Dexamethasone treatment was linked to worse clinical outcomes in patients with sickle cell disease hospitalized for COVID-19.
DAIC
MARCH 6, 2024
Patients with sickle cell disease may be at higher risk of painful crisis and DEFINITY® should be administered with caution. Clinical studies have substantiated the efficacy and safety of DEFINITY in pediatric patients, reported the company, which is Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden.
Let's personalize your content